NUS researchers boost chemotherapy uptake in breast cancer treatment with localised magnetic fields A recent study explained the mechanisms by which pulsed electromagnetic field therapy… CISION PRNewswireJanuary 7, 2025
Press ReleaseASTON MARTIN ARAMCO FORMULA ONE® TEAM ANNOUNCE PEPPERSTONE AS OFFICAL TRADING PARTNER Aston Martin Aramco announce long-term partnership with Pepperstone A global leader in… CISION PRNewswireJanuary 7, 2025
CLO Virtual Fashion Opens New Office in Vietnam in Response to Growth in Southeast Asia CLO Virtual Fashion opens a second Southeast Asia office in Ho Chi… CISION PRNewswireJanuary 7, 2025
Press ReleaseSHOPLINE, the Commerce SaaS and Solution Provider, Teams Up with Tessera to Revolutionize Customer Experience and Elevate Brand Impact Across Asia TAIPEI, Jan. 7, 2025 /PRNewswire/ — As the future of retail shifts… CISION PRNewswireJanuary 7, 2025
The Registrational Clinical Data of Glecirasib was Published in Nature Medicine BEIJING, SHANGHAI and BOSTON, Jan. 7, 2025 /PRNewswire/ — Jacobio Pharma (1167.HK),… CISION PRNewswireJanuary 7, 2025
Press ReleaseYaber at CES 2025: Color the Movie Night Enjoy Stunning Visuals with Yaber’s Powerful K300s, L2 Plus, and T2 Series… CISION PRNewswireJanuary 7, 2025
Press ReleaseAmazfit Announces the Active 2; the Ultimate Everyday Smartwatch for Active and Healthy Living MILPITAS, Calif., Jan. 7, 2025 /PRNewswire/ — Amazfit, a leading global smart… CISION PRNewswireJanuary 7, 2025
Norgine submits Marketing Authorisation Application to the European Medicines Agency for eflornithine (difluoromethylornithine [DFMO]) in high-risk neuroblastoma Back to media releasesNext media release LONDON, Jan. 7, 2025 /PRNewswire/ —… CISION PRNewswireJanuary 7, 2025
